Concepedia

Memantine for Prophylactic Treatment of Migraine Without Aura: A Randomized Double‐Blind Placebo‐Controlled Study

Rezvan Noruzzadeh, Amirhossein Modabbernia, Vajiheh Aghamollaii, Majid Ghaffarpour, Mohammad Hossein Harirchian, Sarvenaz Salahi, Nikta Nikbakht, Nahid Noruzi, Abbas Tafakhori

Headache The Journal of Head and Face Pain · 2015 · 72 citations · 17 references

DOI

Abstract

Memantine might be a tolerable and efficacious option for prophylaxis in patients with migraine without aura. Tolerability, short duration required for titration, and safety profile in pregnancy might give memantine an advantage over other antimigraine medications. The study was registered in the Iranian Registry of Clinical Trials (Registration number: IRCT2013120115616N1).

References

17

The Hospital Anxiety and Depression Scale

A. S. Zigmond, R. P. Snaith · Acta Psychiatrica Scandinavica · 1983 · 45.5K citations

The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research

Daniel J. Buysse, Charles F. Reynolds, T. H. Monk et al. · Psychiatry Research · 1989 · 33.5K citations

, , +17

The International Classification of Headache Disorders: 2nd edition

Jes Olesen, Peter J. Goadsby, Tim Steiner · The Lancet Neurology · 2003 · 5.1K citations

, , +5

The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version.

Ali Montazeri, Mariam Vahdaninia, Mandana Ebrahimi et al. · Health and Quality of Life Outcomes · 2003 · 619 citations · Full text

An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score

Walter F. Stewart, Richard B. Lipton, James Whyte et al. · Neurology · 1999 · 606 citations